Medications

Drug boosts survival for women with advanced ovarian cancer

Women with advanced ovarian cancer often face grim statistics, with less than half surviving for five years after their diagnosis. However, a new study suggests that so-called "maintenance therapy" with a targeted cancer ...

Oncology & Cancer

New screening strategy may catch ovarian cancer at early stages

Evaluating its change over time, CA-125, the protein long-recognized for predicting ovarian cancer recurrence, now shows promise as a screening tool for early-stage disease, according to researchers at The University of Texas ...

Oncology & Cancer

Chemoresponse assay helps boost ovarian cancer survival

This spring, a team of researchers has released results from an eight-year study that shows improved survival rates for women diagnosed with ovarian cancer who undergo cancer tumor testing to determine the best treatment.

Oncology & Cancer

Experts address the latest advances in cervical cancer treatment

Although the incidence of cervical cancer has declined with increased screening and higher uptake of human papillomavirus (HPV) vaccination, cervical cancer remains the second highest cause of cancer mortality among women ...

Obstetrics & gynaecology

Oncologist discusses health disparities in gynecologic cancers

Each year, thousands of women are diagnosed with gynecologic cancers in the U.S. While cervical, ovarian and uterine cancer affects all races, Black women are often diagnosed at later stages and are more likely to die from ...

page 2 from 3